HOME > TOP STORIES

TOP STORIES

REGULATORY Interim Report of Diovan Panel Fails to Lay Bare Who Altered Data, for What Purpose

October 1, 2013
BUSINESS Amgen Astellas BioPharma to Go on Stream Oct. 1; JV Chief Takahashi Eager to Make It a “Category Leader”

September 30, 2013
REGULATORY Japan Health Minister Meets Exec of Swiss Novartis, Seeks Cooperation in Diovan Probe

September 27, 2013
REGULATORY JPWA Seeks Generic Name Listing for Wider Range of Generics

September 27, 2013
BUSINESS 3 Pharma Groups Demand Permanent Introduction of Premium at CSIMC; Healthcare Rep Still Wary

September 26, 2013
BUSINESS Daiichi Sankyo Dogged by Renewed Quality Woes at Ranbaxy; FDA Mute on Details

September 26, 2013
ACADEMIA National University Hospital Council Urges Immediate Check-Up on Hospital’s Clinical Research Systems

September 25, 2013
BUSINESS Unique Marketing System Jacks Up Profits at Vital KSK; Customer-by-Customer Cost Analyses Lend Support

September 24, 2013
REGULATORY FTC’s Legal Intervention in Diovan Issue Possible, but Only with New Facts: Lawyer

September 20, 2013
BUSINESS MTPC Completes Acquisition of Medicago, Now Ready to Bolster Vaccine Development

September 20, 2013
BUSINESS Daiichi Sankyo, Mitsubishi UFJ Capital Establish New Fund to Support Ventures in Japan

September 19, 2013
BUSINESS Demand Growing for Transdermal Patches in Graying Japan, Drug Makers Gear Up for Development

September 18, 2013
REGULATORY MHLW Plans to Establish Ethics Committee Certification System to Improve the Quality of Clinical Research

September 18, 2013
BUSINESS Takeda Grants Arbor Exclusive Rights for Edarbi Family of Products in US

September 17, 2013
ORGANIZATION Transparency Guidelines: JPMA Says Requested Viewers’ Names, Affiliations Could Be Checked before Disclosing Individual Payment Information

September 13, 2013
BUSINESS Nippon Kayaku’s Filing of Remicade Biosimilar Heralds Age of Major Biologic Follow-Ons

September 12, 2013
REGULATORY PMDA Eyes Mandatory Electronic Filings for NDA Clinical Trial Data from FY2016

September 11, 2013
ACADEMIA Use Double-Blind Method to Regain Confidence in Japanese Clinical Trials: Dr Yui of Kyoto Univ. Hospital

September 10, 2013
BUSINESS Wholesalers to Stress that Medical Institutions Will Not Have to Incur Any Losses Due to Consumption Tax Hike

September 10, 2013
REGULATORY Health Ministry to Introduce New System for Online Import and Export Declarations as Early as Next Autumn

September 9, 2013

ページ

Chuikyo Debate on FY2026 Drug Pricing Reform

Chuikyo Backs Draft FY2026 Pricing Reform Outline, Rejects Key Industry Requests

By Takashi Ebisawa

The Ministry of Health, Labor and Welfare (MHLW) on December 12 presented a draft outline of the FY2026 drug pricing…

COLUMN

AI: Your New HR BFF (Not Your Replacement!)

By Philip Carrigan

Let’s ditch the stuffy jargon and talk about AI in HR like real humans.One of the biggest myths floating around is that AI is coming to steal our jobs. Newsflash: that’s not happening. Sure, AI can handle the boring stuff…

COMMENTARY

Radioligand Therapy Faces Capacity Bottleneck in Japan, System Build-Out Needed to Deliver on Promise

By Koji Shimomura

Novartis’ Pluvicto (lutetium vipivotide tetraxetan (177Lu)) won reimbursement listing in Japan in November as a radioligand therapy (RLT) for PSMA-positive…